NO20005217L - DNA som koder for strukturelt protein-1 i infeksiös lakseanemivirus og anvendelse derav - Google Patents

DNA som koder for strukturelt protein-1 i infeksiös lakseanemivirus og anvendelse derav

Info

Publication number
NO20005217L
NO20005217L NO20005217A NO20005217A NO20005217L NO 20005217 L NO20005217 L NO 20005217L NO 20005217 A NO20005217 A NO 20005217A NO 20005217 A NO20005217 A NO 20005217A NO 20005217 L NO20005217 L NO 20005217L
Authority
NO
Norway
Prior art keywords
structural protein
dna encoding
infectious salmon
anemia virus
protein
Prior art date
Application number
NO20005217A
Other languages
English (en)
Other versions
NO20005217D0 (no
NO330866B1 (no
Inventor
Eirik E Biering
Bjoern B Krossoey
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8240749&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20005217(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20005217D0 publication Critical patent/NO20005217D0/no
Publication of NO20005217L publication Critical patent/NO20005217L/no
Publication of NO330866B1 publication Critical patent/NO330866B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20005217A 1999-10-18 2000-10-17 Peptid, vaksine, diagnostisk sett samt anvendelse av en nukleotidsekvens NO330866B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99203401 1999-10-18

Publications (3)

Publication Number Publication Date
NO20005217D0 NO20005217D0 (no) 2000-10-17
NO20005217L true NO20005217L (no) 2001-04-19
NO330866B1 NO330866B1 (no) 2011-08-01

Family

ID=8240749

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005217A NO330866B1 (no) 1999-10-18 2000-10-17 Peptid, vaksine, diagnostisk sett samt anvendelse av en nukleotidsekvens

Country Status (10)

Country Link
US (1) US6471964B1 (no)
EP (1) EP1094069B2 (no)
JP (1) JP4777508B2 (no)
AT (1) ATE286507T1 (no)
AU (1) AU778791B2 (no)
CA (1) CA2321437A1 (no)
DE (1) DE60017229D1 (no)
DK (1) DK1094069T4 (no)
NO (1) NO330866B1 (no)
NZ (1) NZ507530A (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO328740B1 (no) * 1999-08-07 2010-05-03 Novartis Ag Sammensetninger og vaksine, samt anvendelse av sammensetningene for fremstilling av en vaksine for beskyttelse av fisk mot infeksiøs lakseanemivirus

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2402339C (en) * 2000-03-08 2010-01-12 The University Court Of The University Of Aberdeen Viral antigen and vaccine against isav (infectious salmon anaemia virus)
CA2393895A1 (en) * 2001-07-17 2003-01-17 University Of Prince Edward Island Serological test for isav in fish
EP1440086B1 (en) * 2001-10-19 2011-04-13 Intervet International BV Infectious salmon anaemia virus vaccine
TW201139672A (en) 2002-12-13 2011-11-16 Novartis Ag Immunization of fish with plant-expressed recombinant proteins
CA2687208C (en) 2006-12-22 2017-02-14 Soluciones Biotecnologicas Innovacion Ltda Process and formulation for immunizing fish in aquaculture systems
EP2482825B1 (en) 2009-10-02 2016-11-23 The Trustees of Columbia University in the City of New York Piscine reovirus diagnostic compositions
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990063914A (ko) * 1995-10-18 1999-07-26 빌프리더 하이더 이미노아세트산 아미드 및 해충 구제제로서의 그의용도
PT839913E (pt) * 1996-11-04 2006-09-29 Ottawa Health Research Inst Metodo de expressao de polipeptidos em peixe por imerssao numa solucao de adn plasmidico
ATE352624T1 (de) * 1997-11-21 2007-02-15 Serono Genetics Inst Sa Chlamydia pneumoniae genomische sequenzen und polypeptiden, fragmenten und anwendungen davon für nachweis, prevention und heilung
ATE332712T1 (de) * 1999-08-07 2006-08-15 Novartis Pharma Gmbh Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO328740B1 (no) * 1999-08-07 2010-05-03 Novartis Ag Sammensetninger og vaksine, samt anvendelse av sammensetningene for fremstilling av en vaksine for beskyttelse av fisk mot infeksiøs lakseanemivirus

Also Published As

Publication number Publication date
DK1094069T4 (da) 2008-07-21
US6471964B1 (en) 2002-10-29
ATE286507T1 (de) 2005-01-15
JP2001211888A (ja) 2001-08-07
EP1094069B2 (en) 2008-04-23
NO20005217D0 (no) 2000-10-17
EP1094069A1 (en) 2001-04-25
AU778791B2 (en) 2004-12-23
JP4777508B2 (ja) 2011-09-21
CA2321437A1 (en) 2001-04-18
NO330866B1 (no) 2011-08-01
AU6653800A (en) 2001-04-26
DK1094069T3 (da) 2005-05-17
EP1094069B1 (en) 2005-01-05
DE60017229D1 (de) 2005-02-10
NZ507530A (en) 2001-08-31

Similar Documents

Publication Publication Date Title
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CA2005291A1 (en) Feline infectious peritonitis virus diagnostic tools
DE69535061D1 (de) Virale nukleotidsequenz vr-2332 und nutzungsverfahren
CY1106513T1 (el) Λεντινοϊικο τριπλο dna και οχηματα και ανασυνδυασμενα κυτταρα που περιεχουν λεντινοϊικο τριπλο dna
DE60120621D1 (de) Lawsonia intracellularis Impfstoff
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
NO20005217D0 (no) DNA som koder for strukturelt protein-1 i infeksiøs lakseanemivirus og anvendelse derav
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
WO2001021807A8 (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
NO885090L (no) Polypeptider.
ATE332712T1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
WO2001049712A3 (en) Vaccine against isav (infectious salmon anaemia virus)
ATE122055T1 (de) Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung.
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
NO20041564L (no) Infeksios lakse anemi-virus vaksine
WO2002026784A3 (en) Matrix proteins m1 and m2 of infections salmon anaemia virus
WO2002095413A3 (en) Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees